AboubacarTraore

市场分析机构 Santiment 在 X（原Twitter）表示，Bitcoin Ordinals 和 Meme 币市场情绪近期出现波动。分析显示，负面关键词的频率有所增加，可能影响市场走势。Santiment 建议投资者关注这些情绪变化，以便做出更明智的投资决策。

This is a general announcement. Products and services referred to here may not be available in your region.
Fellow Binancians,
As part of the Binance 2026 Ramadan Calendar, we’re pleased to invite you to the Binance MENA Ramadan Iftar Tour 2026, a series of in-person Iftar gatherings hosted across key markets in the MENA region during the holy month of Ramadan.
The Ramadan Iftar Tour brings the Binance community together to connect, share, and celebrate the spirit of Ramadan. Attendees will enjoy a traditional Iftar meal alongside community activities, Binance-themed games, and opportunities to engage with fellow users and Binance representatives.
Seats are limited, and invitations will be sent to selected users via email and Binance App notifications. Users can check their inboxes for invitations.
Activity Period: 2026-02-18 18:00 (UTC+3) to 2026-03-04 22:00 (UTC+4)
Binance MENA Ramadan Iftar Tour 2026 Schedule:
2025-02-25: Manama, Bahrain
18:00 - 22:00 (UTC+3)
2025-02-28: Karachi, Pakistan
17:30 - 22:00 (UTC+5)
2025-03-04: Al Ain, United Arab Emirates
18:00 - 22:00 (UTC+4)
What to Expect at the Binance Ramadan Iftar Tour:
Community Iftar GatheringsBreak your fast with a traditional Iftar meal while connecting with fellow Binance community members.Games and Interactive ActivitiesTake part in Ramadan-themed games, Binance challenges, and interactive experiences.Exclusive Binance Swag and GiveawaysReceive special Binance merchandise and participate in on-site giveaways.Photo Moments and Community HighlightsCapture memories at Binance-branded photo areas and community moments throughout the evening.
Meet and ConnectEngage with Binance users, Angels, and community leaders from your local market.
How to Join:
Participation in the Binance MENA Ramadan Iftar Tour is by invitation only.
Selected users will receive an invitation via email or Binance App notification with registration details. Follow the instructions provided to secure a seat, as spaces are limited and available on a first-come, first-served basis.
More information, including venue confirmations, will be shared with registered attendees ahead of each event.
Terms and Conditions:
Registration is on a first-come, first-served basis and is subject to availability.Binance reserves the right to disqualify any participants displaying signs of fraudulent behavior.Event details, including venue and timings, are subject to change. Registered attendees will be notified of any updates.Binance reserves the right to modify or cancel these events at any time without prior notice.There may be discrepancies between this original content in English and any translated versions. Please refer to the original English version for the most accurate information, in case any discrepancies arise.
Follow Binance MENA on our official X, Instagram, and Telegram channels for real-time updates and content from the Ramadan Tour.
We look forward to celebrating Ramadan with you in person. See you soon.
Thank you for your support!
Binance Team
2025-02-17

CoinMarketCap's Altcoin Season Index is currently at 37, suggesting that Bitcoin is outperforming most altcoins. According to NS3.AI, the index evaluates the price performance of the top 100 cryptocurrencies, excluding stablecoins and wrapped coins, against Bitcoin over the past 90 days. An altcoin season is typically identified when 75% of top altcoins surpass Bitcoin's performance, but the current score is well below this benchmark.

U.S. regulators have declined to review Moderna's innovative mRNA flu vaccine, marking a significant setback for the company as it aims to expand its product offerings beyond its Covid-19 vaccine. Bloomberg posted on X, highlighting the challenges Moderna faces in diversifying its portfolio amid the competitive pharmaceutical landscape. The refusal to review the vaccine could delay Moderna's plans to introduce new mRNA-based products to the market, impacting its growth strategy. Moderna has been striving to leverage its mRNA technology, which gained prominence during the Covid-19 pandemic, to develop vaccines for other diseases. The company's efforts to broaden its product range are crucial as it seeks to maintain its position in the industry and drive future growth. The decision by U.S. regulators underscores the hurdles that pharmaceutical companies encounter in bringing new vaccines to market, particularly those utilizing novel technologies. Moderna's mRNA flu vaccine was anticipated to be a key component of its strategy to diversify its offerings and reduce reliance on its Covid-19 vaccine. The company's focus on mRNA technology has been a central aspect of its business model, and the refusal to review the flu vaccine represents a challenge in its pursuit of innovation. As Moderna navigates this setback, the company will need to reassess its approach to product development and regulatory engagement to achieve its long-term objectives.